VIR-2218

· Brii Biosciences Limited

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for VIR-2218, covering 2021-12-13 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection [Phase 2]